Additionally, the glucose-deficient environment downregulates MHC-I expression on tumor cells, resulting in diminished T cell function because of the insensitivity to IFN-γ and the IFN-γ-STAT1 pathway, which can be rescued by a PIK3 inhibitor (52). This evidence concerns the gene IFNG and neoplasm.